Re-Vana Therapeutics | Investor profile | Foundersuite

Investor info

Type

Venture Capital

Stage focus

Early stage VC

Industry focus

Description

Re-Vana Therapeutics is a biotechnology company focused on developing innovative therapies to treat fibrotic diseases by targeting key biological pathways. Their approach aims to restore normal tissue function and improve patient outcomes through advanced scientific research.

Previous investments

Company
Amount
Round

Example example company Inc
1000000
Investor meetings
Company & Company
11000000
Series C funding
Example
524000
Seed round A

Connected people

Email visible after logging in

Example Exampleexample[email protected]
Example Exampleexample
Notexample Examplenotexample example[email protected]
Example Examplenotexampleexample example[email protected]
Example Exampleexample[email protected]
Example Exampleexample[email protected]

X Feed

Click here to see tweets by Re-Vana Therapeutics

See other investors focused on

Enterprise Software

Other investors you may be interested in